Criteria of withdrawal of first-line DMT and substitution for second-line drugs (treatment escalation) basing on MRI results (About the article A.N. Boyko, at al. «The choice of the optimal drug for pathogenic treatment of multiple sclerosis: a current state of the problem» publishe in №10(2), 2014)

Krotenkova M.V.; Morozova S.N.; Briukhov V.V.; Zavalishin I.A.; Peresedova A.V.

doi:https://doi.org/10.17116/jnevro20151152279-80

Krotenkova M.V.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Morozova S.N.

Research Center of Neurology, Russian Academy of Sciences, Moscow

Briukhov V.V.

Zavalishin I.A.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Peresedova A.V.

Research Center of Neurology, Moscow, Russia

Criteria of withdrawal of first-line DMT and substitution for second-line drugs (treatment escalation) basing on MRI results (About the article A.N. Boyko, at al. «The choice of the optimal drug for pathogenic treatment of multiple sclerosis: a current state of the problem» publishe in №10(2), 2014)

Authors:

Krotenkova M.V., Morozova S.N., Briukhov V.V., Zavalishin I.A., Peresedova A.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(2‑2): 79‑80

DOI: 10.17116/jnevro20151152279-80

Read: 796 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Krotenkova MV, Morozova SN, Briukhov VV, Zavalishin IA, Peresedova AV. Criteria of withdrawal of first-line DMT and substitution for second-line drugs (treatment escalation) basing on MRI results (About the article A.N. Boyko, at al. «The choice of the optimal drug for pathogenic treatment of multiple sclerosis: a current state of the problem» publishe in №10(2), 2014). S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(2‑2):79‑80. (In Russ.)
https://doi.org/10.17116/jnevro20151152279-80